Email Icon Facebook icon Twitter Icon GooglePlus Icon Contact

User Top Menu

Achieving Effective Treatment for Early Psychosis in the United States

by Hakon Heimer Posted on 28 Feb 2017

LisaDixonOn March 22, 2017, SRF held a webinar to discuss the paths and barriers to widespread effective care for people in the early stages of psychosis in the United States. Lisa Dixon of Columbia University led the discussion, presenting ideas that she has laid out recently in an editorial in JAMA Psychiatry (Dixon, 2017). Our panel of discussants included Rebecca Farley of the National Council on Behavioral Health, Robert Heinssen of the National Institute for Mental Health, Nev Jones of Felton Institute, David Shern of the National Association of State Mental Health Program Directors, and Andrew Sperling of the National Alliance on Mental Illness

Coordinated specialty care (CSC) for people in early psychosis has shown promise in other countries, and research such as the RAISE study has demonstrated the feasibility of establishing such programs in the United States. (For an overview of coordinated specialty care, see "Evidence-based Treatments for First Episode Psychosis: Components of Coordinated Specialty Care," by Heinssen et al., 2014, available at the NIMH website.)

However, as Dixon points out, there are a number of barriers that need to be overcome to “get over the hump” and provide such services to everyone experiencing psychosis, and foremost among these obstacles is figuring out how to pay for CSC with a combination of public and private funds. Other hurdles include workforce development; getting the word out about early treatment; ensuring fidelity to proven methods and protocols; measuring outcomes; and getting young people, especially consumers, involved.

 

Listen to the Webinar

 

Lisa Dixon's Presentation

 

Nev Jones' Presentation